(Q34635511)

English

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

16

object named as

P Fenaux

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Claude Preudhomme

20

object named as

C Preudhomme

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Olivier Nibourel

3

object named as

O Nibourel

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

A Renneville

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

N Boissel

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Berthon

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

N Helevaut

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Gardin

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J-M Cayuela

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

S Hayette

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

O Reman

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

N Contentin

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

D Bordessoule

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Pautas

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

S de Botton

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

T de Revel

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Terre

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

X Thomas

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

S Castaigne

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

H Dombret

19

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

13 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1247-1254

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

https://scigraph.springernature.com/pub.10.1038/leu.2011.382

0 references

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Array-based genomic resequencing of human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

The epigenomics of cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

SIFT: Predicting amino acid changes that affect protein function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

DNMT3A mutations are rare in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

High Expression Levels of theETS-Related Gene,ERG, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

21 January 2018

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

DNMT3A mutations in myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.382

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2011.382

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34635511&oldid=1858101844"